Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

0(0%)

Results Posted

40%(2 trials)

Terminated

1(13%)

Phase Distribution

Ph phase_1

75%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

6(75.0%)

Phase 2Efficacy & side effects

2(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(5)

Terminated(2)

Detailed Status

Completed5

Withdrawn1

Terminated1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 2

Trials by Phase

Phase 16 (75.0%)

Phase 22 (25.0%)

Trials by Status

withdrawn113%

terminated113%

completed563%

not_yet_recruiting113%

Recent Activity

0 active trials

Showing 5 of 8

not_yet_recruitingphase_1

Clinical Trials (8)

Showing 8 of 8 trials

NCT06704347Phase 1

Safety Study of XT-150 in Participants With ALS

Not Yet Recruiting

NCT04124042Phase 2

Efficacy and Safety of XT-150 in Osteoarthritis of the Knee

Completed

NCT05196919Phase 2

Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain

Completed

NCT04466410Phase 1

Safety and Efficacy of XT-150 for Treatment of Neuropathic Pain

Terminated

NCT04841512Phase 1

Preliminary Safety and Efficacy of XT-150 in Facet Joint Osteoarthritis

Withdrawn

NCT03769662Phase 1

Follow on Extension of XT-150-1-0201

Completed

NCT03477487Phase 1

Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain

Completed

NCT03282149Phase 1

Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain

Completed

All 8 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 8